As research into a cure — or at least treatment — for Alzheimer’s continues, scientists are looking beyond the pathways of targeting tau or…
Last week, Biogen announced that its Alzheimer’s drug aducanumab was effective in combating Alzheimer’s disease, and that it would be reviving a trial cancelled…
When biotechnology company Biogen announced the cancellation of the trial for their Alzheimer’s drug aducanumab, nearly 3,500 trial participants were left in limbo. Now,…
SAN DIEGO — The scientific data was virtually unreadable, the explanations often too complex for the layman or woman to understand. But there was…
nA highly anticipated Alzheimer’s conference opened here last night with reports about a powerful new drug for treating dementia-related delusions. ACADIA Pharmaceuticals presented its…
An Alzheimer’s drug that attacks tau proteins is now being moved into new clinical trials in the U.S. and Europe, according to Singapore-based pharmaceutical…
Was it too good to be true? China last week awarded conditional approval for a new seaweed-based drug for Alzheimer’s, but experts in the…
Scientists and analysts greeted yesterday’s announcement that Biogen is trying to resurrect aducanumab, its experimental Alzheimer’s drug, with caution and outright skepticism. Minutes after…
Researchers at the Yale School of Medicine have discovered that insulin nasal spray may improve cognitive function in obese and pre-diabetic adolescents, supporting previous…
As a teenager, I would visit my grandmother over the summer and she was always the life of the party. She introduced me to…
A potent group of antipsychotic drugs used to treat delirium and dementia are not effective, according to a study published in the New England…
A report by the AARP has found that most dementia patients—around 70 percent—are kept on prescription drugs much longer than they’ve been found to be…
Any Alzheimer’s drug under development has a complicated journey from formulation to clinical trials to potentially getting in the hands of patients. We spoke…
Experimental drugs for Alzheimer’s disease have a 99.6 percent failure rate. Not such a great track record. But, according to an expert in the…
While there is currently no treatment for Alzheimer’s disease, a drug called Aricept can temporarily ease the symptoms for a short period of time….